Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Immuneering Corporation Announces Grants of Inducement Awards

$IMRXPress releaseJul 17, 2026, 4:05 PM ETRead the release

Immuneering Corporation granted stock options to new CFO Andrew Gengos and a non-executive employee as employment inducement awards effective July 16, 2026. Mr. Gengos received an option to purchase 650,000 shares of Class A common stock at an exercise price of $4.78 per share, which was the closing price on the grant date.

Key figures

Cfo exercise price
4.78
Cfo options granted
650000
Employee exercise price
4.78
Employee options granted
32400

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    IMRX: Immuneering Corporation Announces Grants of Inducement Awards — AI Analysis | Signal8